Paper23973155
The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial.
Gallelli L and 12 others. Osteoarthritis Cartilage, 2013. Cited by 108 papers, by iCite.
Cite this record
ConductScience Library. The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial. Papers, record 23973155. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23973155
- Disease
- osteoarthritis214 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial.
- PubMed
- Publication types
- Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Inflammatory Agents, Non-Steroidal | Major topic |
| Diclofenac | Major topic |
| Ibuprofen | Major topic |
| Osteoarthritis, Knee | Major topic |
| Pyrazoles | Major topic |
| Sulfonamides | Major topic |
| Aged | |
| Aged, 80 and over | |
| Celecoxib | |
| Cyclooxygenase 2 Inhibitors | |
| Cytokines | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Quality of Life | |
| Signal Transduction | |
| Synovial Fluid | |
| Treatment Outcome |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01860833 | NSAID Treatment in Knee Osteoarthritis | Derived from the trial | Yes |
Source ClinicalTrials.gov
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 108 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42857734 | Targeting Inflammation in Osteoarthritis Pain: A Phenotype-Driven Approach. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42857734 | PubMed |
| 42732269 | Recovery Trajectory of Range of Motion and Its Association With Patient Factors During Early Postoperative Stiffness After Arthroscopic Rotator Cuff Repair. | Orthop J Sports Med | 2026 | https://conductscience.org/library/papers/42732269 | PubMed |
| 41526427 | The effect of preemptive use of nonsteroidal anti-inflammatory drug on inflammation, oxidative stress, and wound healing. | Sci Rep | 2026 | https://conductscience.org/library/papers/41526427 | PubMed |
| 41075072 | Targeting the senescence-associated secretory phenotype to modify osteoarthritis in aging. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/41075072 | PubMed |
| 41063134 | Limited effects of non-steroidal anti-inflammatory drugs (NSAIDs) on imaging outcomes in osteoarthritis: observational data from the osteoarthritis initiative (OAI). | BMC Musculoskelet Disord | 2025 | https://conductscience.org/library/papers/41063134 | PubMed |
| 40732352 | Comparative Efficacy and Safety of Two Different Formulations of Linear Hyaluronic Acid in Patients with Knee Osteoarthritis. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40732352 | PubMed |
| 40143081 | Efficacy and Safety of Intra-Articular Therapy with Cross-Linked Hyaluronic Acid in Patients with Knee Osteoarthritis. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40143081 | PubMed |
| 39769371 | The Effect of Intravascular Laser Irradiation of Blood on Serum Biomarkers and Clinical Outcome in Knee Osteoarthritis Patients: A Double-Blind Randomized Control Trial. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39769371 | PubMed |
| 39194747 | The Oral Administration of Lactobacillus delbrueckii subsp. lactis 557 (LDL557) Ameliorates the Progression of Monosodium Iodoacetate-Induced Osteoarthritis. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/39194747 | PubMed |
| 38961031 | Inflammation as a therapeutic target for osteoarthritis: A literature review of clinical trials. | Clin Rheumatol | 2024 | https://conductscience.org/library/papers/38961031 | PubMed |
| 38952995 | Transforming Growth Factor-β-Activated Kinase 1 (TAK1) Alleviates Inflammatory Joint Pain in Osteoarthritis and Gouty Arthritis Preclinical Models. | J Pain Res | 2024 | https://conductscience.org/library/papers/38952995 | PubMed |
| 38799798 | Imrecoxib: Advances in Pharmacology and Therapeutics. | Drug Des Devel Ther | 2024 | https://conductscience.org/library/papers/38799798 | PubMed |
| 38793119 | Interactions and Trends of Interleukins, PAI-1, CRP, and TNF-α in Inflammatory Responses during the Perioperative Period of Joint Arthroplasty: Implications for Pain Management-A Narrative Review. | J Pers Med | 2024 | https://conductscience.org/library/papers/38793119 | PubMed |
| 38529299 | Effect of anti-inflammatory treatments on patient outcomes and concentrations of inflammatory modulators in the post-surgical and post-traumatic tibiofemoral joint setting: a narrative review. | Ann Jt | 2024 | https://conductscience.org/library/papers/38529299 | PubMed |
| 38529294 | Inflammatory synovial biomarkers and state of the tibiofemoral joint in the post-surgical settings: a narrative review. | Ann Jt | 2024 | https://conductscience.org/library/papers/38529294 | PubMed |
| 38464433 | Arthroscopic rotator cuff repair in patients over 65 years of age: successful functional outcomes and a high tendon integrity rate can be obtained after surgery. | JSES Int | 2024 | https://conductscience.org/library/papers/38464433 | PubMed |
| 38347301 | Does non-steroidal anti-inflammatory drugs-related preemptive analgesia modulate SOCS3/IL-6 pathway in oral surgery? | Inflammopharmacology | 2024 | https://conductscience.org/library/papers/38347301 | PubMed |
| 37799383 | Advancing drug delivery to articular cartilage: From single to multiple strategies. | Acta Pharm Sin B | 2023 | https://conductscience.org/library/papers/37799383 | PubMed |
| 37489445 | Actigraphy Analysis of Sleep Associates with Salivary IL-6 Concentration in Institutionalized Older Individuals. | Diseases | 2023 | https://conductscience.org/library/papers/37489445 | PubMed |
| 37111650 | The Pharmacological Treatment of Chronic Pain: From Guidelines to Daily Clinical Practice. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37111650 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CXCL8 | 3576 | PubTator's text mining | https://conductscience.org/library/genes/3576 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Drugs3
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| CELECOXIB | CHEMBL118 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL118 | ChEMBL |
| DICLOFENAC | CHEMBL139 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL139 | ChEMBL |
| IBUPROFEN | CHEMBL521 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL521 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23973155
GET https://conductscience.org/api/papers/v1/23973155/cited_by?page=2